Termination of Consulting Arrangement with Dr. George Shapiro
Exhibit 10.12
ORGANICELL REGENERATIVE MEDICINE, INC.
4045 SHERIDAN AVENUE
SUITE 239
MIAMI BEACH, FLORIDA 33140
August 19, 2022
Dr. George Shapiro
_________________
_________________
Dear Dr. Shapiro:
Reference is made to that certain consulting arrangement by and between Organicell Regenerative Medicine, Inc., a Nevada corporation (the “Company”) and Dr. George Shapiro (“Executive”), which was initially approved by the Company’s Board of Directors effective March 1, 2020 and amended effective May 1, 2021 (the “Consulting Arrangement”). In connection with a capital and management restructuring of the Company, the Company and Executive as follows:
1. The Consulting Arrangement is hereby terminated and is of no further force and effect.
2. Executive waives the right to receive all accrued but unpaid compensation as of the date of this letter agreement under the Consulting Arrangement. In exchange therefor, the Company shall issue to Executive ten-year warrants to purchase up to 3,150,000 shares of the Company’s common stock at an price of $0.02 per share, in the form attached hereto as Exhibit A.
If the foregoing correctly set forth our agreement, please countersign this letter agreement below.
Very truly yours,
ORGANICELL REGENERATIVE MEDICINE, INC.
By: | /s/ Matthew Sinnreich, | |
Matthew Sinnreich, Acting Chief Executive Officer |
ACCEPTED AND AGREED TO THIS 19th DAY OF AUGUST, 2022
/s/ George Shapiro | ||
Dr. George Shapiro | ||
8/19/2022 |
Page 1 of 1